Just to extend on II's comment. We are keeping our trials to indications within the confines of the blood brain barrier. drugs outside of that region for 11bhsd1 inhibition already exist. I'm unsure why post myocardial infarction was on Bills to do list last year though?
Ann: Market Update and ACW to Participate in BIO Digital, page-89
Add ACW (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $76.57M | |||
| Open | High | Low | Value | Volume |
| 2.6¢ | 2.7¢ | 2.6¢ | $51.00K | 1.961M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 3393264 | 2.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.7¢ | 6272360 | 9 |
View Market Depth
| Last trade - 15.11pm 02/10/2024 (20 minute delay) ? |
| ACW (ASX) Chart |